I now have all the material needed for a thorough answer. Here it is:
Ehlers-Danlos Syndromes (EDS)
EDS is a group of genetically distinct connective tissue disorders characterized by defects in collagen synthesis or structure, resulting in skin fragility, joint hypermobility, and potential organ complications. The 2017 reclassification recognizes 13 subtypes.
- Prevalence: ~1 in 5,000 births overall
- Classical EDS: 1 in 10,000-20,000 newborns
- Vascular EDS: ~1 in 50,000-200,000 (rarest, most dangerous)
Pathophysiology
All EDS subtypes converge on a final common pathway: defective collagen. Different mutations affect different collagen types:
| Mechanism | Subtype | Gene | Inheritance |
|---|
| Deficient type V collagen | Classical EDS | COL5A1, COL5A2 | Autosomal dominant (AD) |
| Deficient type III collagen | Vascular EDS | COL3A1 | AD |
| Deficient lysyl hydroxylase (impaired collagen crosslinks) | Kyphoscoliotic EDS | PLOD1 | Autosomal recessive (AR) |
| Type I collagen defect | Arthrochalasia EDS | COL1A1, COL1A2 | AD |
| Tenascin-X deficiency | Classical-like EDS | TNXB | AR |
Approximately 30 types of collagen exist; mutations in the genes encoding them explain much of the clinical heterogeneity across subtypes. Because the abnormal collagen fibers lack adequate tensile strength, all collagen-rich tissues are affected - skin, ligaments, joints, blood vessels, and hollow organs.
The 13 Subtypes (2017 Classification)
- Classical (cEDS) - COL5A1/COL5A2; hyperextensible fragile skin, atrophic scarring, joint hypermobility
- Classical-like - TNXB; similar to classical but without atrophic scars
- Cardiac-valvular - COL1A2; severe mitral/aortic valve disease
- Vascular (vEDS) - COL3A1; arterial/organ rupture risk
- Hypermobile (hEDS) - unknown gene; most common, joint hypermobility dominant
- Arthrochalasia - COL1A1/COL1A2; congenital hip dislocation
- Dermatosparaxis - ADAMTS2; extreme skin fragility, sagging redundant skin
- Kyphoscoliotic - PLOD1; congenital scoliosis, ocular fragility
- Brittle Cornea Syndrome - ZNF469, PRDM5
- Spondylodysplastic - B4GALT7, B3GALT6
- Musculocontractural - CHST14, DSE
- Myopathic - COL12A1
- Periodontal - C1R, C1S
Clinical Features
Cardinal triad (common to most variants):
1. Skin Findings
Marked skin hyperextensibility - the skin stretches dramatically but recoils to normal position (unlike cutis laxa). Skin can be stretched >1.5 cm on the distal forearm and >3 cm at the neck/elbow/knees.
- Soft, velvety, "doughy" texture
- Easy bruising, with normal platelet function and coagulation tests (reflects structural weakness, not coagulopathy)
- Fragility with wound healing complications - gaping defects from minor injuries, thin atrophic "cigarette paper" scars
- Molluscoid pseudotumors over pressure points
2. Joint Hypermobility
Joint hyperextensibility - the "virtuosity" of extreme ranges of motion, as seen in contortionists, often represents a mild EDS variant.
- Joints bend far beyond normal range (e.g., thumb can touch the forearm, knee flexion approaching a right angle)
- Recurrent joint dislocations
- Chronic musculoskeletal pain
- Increased proprioceptive dysfunction
3. Structural Failure of Internal Organs
The most serious complications depend on subtype:
- Arterial rupture (vascular EDS) - spontaneous rupture of medium/large vessels, including the aorta
- Colon/uterine rupture (vascular EDS)
- Ocular fragility - corneal rupture, retinal detachment (kyphoscoliotic EDS)
- Diaphragmatic hernia (classical EDS)
- Aortic root dilation / mitral valve prolapse (various subtypes)
Vascular EDS - The Most Dangerous Subtype
Caused by dominant-negative mutations in COL3A1 (over 320 mutations described, typically exon-skipping or missense). Type III collagen is a homotrimer, so even one mutant chain disrupts most fibrils - leading to:
- Reduced type III collagen in dermis, vessels, and viscera
- Intracellular accumulation of misfolded procollagen
- Weakness of blood vessel walls and hollow organs
Clinical hallmarks: thin translucent skin with visible veins, characteristic facial features (thin nose, small ears, sunken cheeks), acrogeria (premature aging of hands/feet), and a high lifetime risk of arterial or organ rupture.
Diagnosis
- Clinical criteria (Beighton score for joint hypermobility + skin + scarring findings)
- Skin hyperextensibility assessment: skin stretched at the volar forearm - positive if >1.5 cm on forearms/dorsal hands or >3 cm at neck/elbows/knees
- Electron microscopy of skin biopsy: abnormal collagen fibril morphology (routine histopathology is typically normal)
- Genetic testing: next-generation sequencing (NGS) panels are now preferred - parallel sequencing of all known EDS genes; whole-exome sequencing if no mutation found
- Biochemical tests: type III procollagen analysis for vascular EDS
- Coagulation tests are normal (helping distinguish bruising from coagulopathy)
Management
There is no cure - management is supportive and preventive:
| Area | Approach |
|---|
| Joint protection | Physical therapy, low-impact exercise, bracing; avoid high-impact/contact sports |
| Wound care | Careful surgical technique, deep sutures, prolonged closure; warn surgeons before any procedure |
| Vascular EDS | Regular imaging (CT/MRI) of aorta and major vessels; avoid invasive procedures where possible; beta-blockers (celiprolol has RCT evidence for vascular EDS specifically) |
| Pain | Multidisciplinary pain management |
| Cardiac | Echocardiography for valve and aortic root assessment |
| Pregnancy | High-risk obstetric care; vascular EDS carries significant maternal mortality risk |
| Genetics referral | Cascade testing of first-degree relatives |
Key Distinctions from Similar Conditions
| Feature | EDS | Marfan Syndrome | Cutis Laxa |
|---|
| Skin recoil after stretching | Yes (snaps back) | Yes | No (hangs loosely) |
| Gene | COL5A1 / COL3A1 etc. | FBN1 (fibrillin-1) | ELN, FBLN5 etc. |
| Tall stature/arachnodactyly | No | Yes | No |
| Coagulation tests | Normal | Normal | Normal |
| Ocular lens dislocation | Occasional | Yes (upward) | No |
Recent Evidence (2024-2026)
- A 2025 systematic review and meta-analysis (PMID: 40542421) quantified vascular complication prevalence in EDS.
- A 2025 meta-analysis (PMID: 40145613) found significantly elevated autism prevalence in patients with hypermobile EDS and joint hypermobility spectrum disorders.
- A 2024 systematic review (PMID: 38926786) documented the serious risks of vascular EDS in pregnancy, including maternal mortality.
Sources: Robbins & Kumar Basic Pathology; Andrews' Diseases of the Skin; Fitzpatrick's Dermatology (Vol. 1-2); Bradley and Daroff's Neurology in Clinical Practice; Goldman-Cecil Medicine.